Professor Andrew Hill has been appointed Director of the La Trobe Institute for Molecular Science (LIMS).
“Professor Hill is an outstanding scientist and an expert on neurodegenerative diseases,” said Professor Robert Pike, Pro Vice-Chancellor of the College of Science, Health and Engineering. “His leadership experience as Head of Biochemistry and Genetics, and Director of the University’s Understanding Disease Research Focus Area, will be of great benefit to LIMS, which is known for its strong research environment and industry partnerships.”
Professor Hill obtained his PhD at Imperial College, London. He held postdoctoral positions in the MRC Prion Unit (London) and the Department of Pathology at The University of Melbourne as a Wellcome Trust Prize Travelling Research Fellow.
Professor Hill joined the Department of Biochemistry and Molecular Biology at The University of Melbourne in 2002 and moved his laboratory into the Bio21 Institute when it opened in 2005. In 2015, Professor Hill was appointed Head of Biochemistry and Genetics at La Trobe University and Director of the University’s Research Focus Area, Understanding Disease.
Professor Hill’s research team uses in vitro and in vivo models to look at how abnormal proteins and RNA travel from cell to cell and are involved in neurodegenerative diseases. His laboratory also works on the biology of small noncoding RNA and their potential use as diagnostics in neurological and infectious diseases.
Professor Hill has published over 150 research papers and edited three books. He is also the recipient of several research awards and fellowships. In 2016 he was elected President of the International Society of Extracellular Vesicles.
“It is an honour to be appointed Director of LIMS,” said Professor Hill. “I look forward to working with the Institute’s scientists to support the world-class research being carried out here.”